Clinical Trial

Nanozymes in Endodontics

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The antimicrobial efficacy and healing potential of clinically approved ferumoxytol nanozymes versus the standard 3% NaOCl irrigant will be evaluated in adults undergoing endodontic treatment. Building on prior protocols that demonstrated ferumoxytol nanozymes antimicrobial activity as a root canal irrigant, ferumoxytol solution will be applied topically, assessment of clinical and radiographical findings will determine its potential as a novel disinfection and its long-term outcome.
Trial Details
NCT Number NCT07518901
Lead Sponsor University of Pennsylvania
Conditions Apical Periodontitis, Endodontic Disease, Root Canal Infection
Enrollment 72 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-09